[1] LUECK C, STADLER M, KOENECKE C, et al. Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit:a retrospective longitudinal analysis of 942 patients[J].Intensive Care Med,2018,44(9):1483-1492. [2] PETSATODIS G E, ANTONARAKOS P D, CHRISTODOULOU AG, et al.Cementless total hip arthroplasty for osteonecrosis of the femoral head after allogenic bone marrow transplantation[J]. J Arthroplasty,2009,24(3):414-420. [3] SCHULTE C M, BEELEN D W. Bone loss following hematopoietic stem cell transplantation:a long-term follow-up[J]. Blood,2004,103(10):3635-3643. [4] TORⅡ Y, HASEGAWA Y, KUBO T, et al. Osteonecrosis of the femoral head after allogeneic bone marrow transplantation[J]. Clin Orthop Relat Res,2001,382:124-132. [5] LUBNER M G, MENIAS C O, AGRONS M, et al. Imaging of abdominal and pelvic manifestations of graft-versus-host disease after hematopoietic stem cell transplant[J]. Am J Roentgenol, 2017,209(1):33-45. [6] LEDFORD C K, VAP A R, BOLOGNESI M P, et al. Total hip arthroplasty in very young bone marrow transplant patients[J]. J Surg Orthop Adv, 2015,24(2):99-104. [7] VIJAPURA A, LEVINE H B, DONATO M, et al.Total hip arthroplasty in patients with avascular necrosis after hematopoietic stem cell transplantation[J]. Orthopedics,2018,41(2):e257-e261. [8] 李子荣, 孙伟, 屈辉,等. 皮质类固醇与骨坏死关系的临床研究[J]. 中华外科杂志, 2005,43(16):1048-1053. [9] CAMPBELL S, SUN C L, KURIAN S, et al. Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation[J]. Cancer,2009,115(18):4127-4135. [10] WIESMANN A, PEREIRA P, BÖHM P, et al. Avascular necrosis of bone following allogeneic stem cell transplantation:MR screening and therapeutic options[J]. Bone Marrow Transplant, 1998, 22(6):565-569. [11] MARSTON S B, GILLINGHAM K, BAILEY R F, et al. Osteonecrosis of the femoral head after solid organ transplantation:a prospective study[J]. J Bone Joint Surg Am, 2002, 84(12):2145-2151. [12] BOQUET J, GOFFIN E, POILVACHE P. Outcome of total knee arthroplasties after renal transplantation[J]. Arch Orthop Trauma Surg, 2008, 128(12):1345-1348. [13] LEDFORD C K, WATTERS T S, WELLMAN S S, et al. Risk versus reward:total joint arthroplasty outcomes after various solid organ transplantations[J]. J Arthroplasty, 2014, 29(8):1548-1552. [14] ZADEGAN F, RAOULD A, BIZOT P, et al. Osteonecrosis after allogeneic bone marrow transplantation[J]. Clin Orthop Relat Res, 2008, 466(2):287-293. [15] CHALMERS B P, LEDFORD C K, STATZ J M, et al. What risks are associated with primary THA in recipients of hematopoietic stem cell transplantation?[J]. Clin Orthop Relat Res, 2017, 475(2):475-480. [16] MCCLUNE B, MAJHAIL N S, FLOWERS M E. Bone loss and avascular necrosis of bone after hematopoietic cell transplantation[J]. Semin Hematol, 2012, 49(1):59-65. [17] GONSALVES A, CARRIER M, WELLS P S, et al. Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation[J]. J Thromb Haemost, 2008, 6(9):1468-1473. [18] GERBER DE, SEGAL JB, LEVY MY, et al. The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation:implications for VTE prevention[J]. Blood, 2008, 112(3):504-510. [19] PIHUSCH R, SALAT C, SCHMIDT E, et al. Hemostatic complications in bone marrow transplantation:a retrospective analysis of 447 patients[J]. Transplantation, 2002, 74(9):1303-1309. |